China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...
Disparities in liver cancer risk and outcomes in the LGBTQ community: A literature review. Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A ...
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...
Each guideline was checked for the following topics: prevention, screening and surveillance, diagnosis, clinical staging, curative treatment, trans-arterial therapies and systemic therapies.
(JAMA Network Open) A single-center trial favored non-contrast MRI over ultrasound for hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis. (Gastroenterology) And for ...
Japanese researchers sought to build upon prior studies demonstrating the feasibility of liver resection in geriatric hepatocellular carcinoma patients, particularly in those undergoing major ...
Hundreds of a people who have chronic liver disease are being helped by an NHS trust's service that helps them attend vital ...
A newly developed nomogram predicts preoperative microvascular invasion in patients with HCC, improving surgical planning and outcomes.
Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.
Background and Aim: Hepatocellular carcinoma (HCC) is the third most common reason for cancer-related death worldwide. Many countries either lack appropriate clinical practice guidelines for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results